These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26805076)

  • 41. A case of unresectable gallbladder cancer responding to gemcitabine after metallic biliary stent implantation.
    Matsutani T; Uchida E; Yokoyama T; Matsushita A; Matsuda A; Sasajima K
    J Nippon Med Sch; 2009 Oct; 76(5):253-7. PubMed ID: 19915309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A case of unresectable advanced gallbladder cancer successfully treated by a combined administration of gemcitabine + CDDP].
    Makino H; Kametaka H; Koyama T; Seike K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2714-6. PubMed ID: 21224689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Curative resection of stage IV advanced gallbladder cancer following combined treatment with gemcitabine and CDDP].
    Adikrisna R; Nakamura N; Irie T; Matsumura S; Tanaka S; Arii S
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):117-20. PubMed ID: 24423965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.
    Meyerhardt JA; Zhu AX; Stuart K; Ryan DP; Blaszkowsky L; Lehman N; Earle CC; Kulke MH; Bhargava P; Fuchs CS
    Dig Dis Sci; 2008 Feb; 53(2):564-70. PubMed ID: 17597402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience.
    Kumar S; Masood N; Shaikh AJ; Valimuhammad AT; Haider G; Lal A; Niamatullah N
    Asian Pac J Cancer Prev; 2009; 10(3):463-6. PubMed ID: 19640192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of gallbladder cancer which completely responded to gemcitabine].
    Yoshida R; Matsuda T; Watanabe T; Iwadou H; Hunabiki K; Kamikawa Y
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1771-3. PubMed ID: 20841944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
    Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T
    Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Gallbladder Cancer with Multiple Liver Metastases Completely Responding to Gemcitabile plus Cisplatin Chemotherapy-A Case Report].
    Jin H; Ichisawa A; Hagiwara Y; Hara Y; Kimura T; Yonaiyama S; Yoshikawa T; Nakai M; Tokura T; Aoki K; Kawashima H; Toyoki Y; Endo M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):364-366. PubMed ID: 32381990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A successful case with TS-1+CDDP chemotherapy for recurrent gastric cancer].
    Ogasawara T; Ootsuka Y; Nakano S; Shida T; Nomura S; Kin M; Takahashi M; Komatsu T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1533-5. PubMed ID: 25731243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downsizing Chemotherapy for Initially Unresectable Locally Advanced Biliary Tract Cancer Patients Treated with Gemcitabine Plus Cisplatin Combination Therapy Followed by Radical Surgery.
    Kato A; Shimizu H; Ohtsuka M; Yoshitomi H; Furukawa K; Takayashiki T; Nakadai E; Kishimoto T; Nakatani Y; Yoshidome H; Miyazaki M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1093-9. PubMed ID: 26240009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case report--The marked response to gemcitabine combined with irinotecan and low-dose cisplatin chemotherapy for advanced gastric cancer with multiple liver metastases.
    Teraishi F; Uno F; Kagawa S; Gochi A; Fujiwara T; Tanaka N
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1885-7. PubMed ID: 17212136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer.
    Lee KJ; Yi SW; Cha J; Seong J; Bang S; Song SY; Kim HM; Park SW
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):841-6. PubMed ID: 27586966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trial.
    Sharma A; Kalyan Mohanti B; Pal Chaudhary S; Sreenivas V; Kumar Sahoo R; Kumar Shukla N; Thulkar S; Pal S; Deo SV; Pathy S; Ranjan Dash N; Kumar S; Bhatnagar S; Kumar R; Mishra S; Sahni P; Iyer VK; Raina V
    Eur J Cancer; 2019 Dec; 123():162-170. PubMed ID: 31707181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A case of long-term survival after aggressive surgery for Stage IV gallbladder carcinoma].
    Shinmura K; Kaiho T; Yanagisawa S; Okamoto R; Nishimura M; Kobayashi S; Okaniwa A; Nomura S; Tsuchiya S; Miyazaki M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1768-70. PubMed ID: 24393916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients.
    Kim BJ; Hyung J; Yoo C; Kim KP; Park SJ; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Park JH; Cho H; Ryoo BY; Chang HM
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):209-215. PubMed ID: 28597043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of disease-free, long survival in a patient with mixed adenoneuroendocrine carcinoma of the gallbladder treated with induction CDDP/CPT-11 chemotherapy and resection].
    Tani S; Yamagishi S; Fukunaga K; Morita M; Sonoda T; Murao S; Ikuta S; Kakuno A; Yamanaka N
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):113-7. PubMed ID: 25596692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma - a retrospective study.
    Croitoru A; Gramaticu I; Dinu I; Gheorghe L; Alexandrescu S; Buica F; Luca I; Becheanu G; Herlea V; Simionov I; Hrehoret D; Lupescu I; Popescu I; Diculescu M
    J Gastrointestin Liver Dis; 2012 Sep; 21(3):277-84. PubMed ID: 23012669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A long-term survivor of advanced gallbladder carcinoma treated with curative operation and hepatic arterial infusion].
    Nogita H; Uchida S; Ishikawa H; Hisaka T; Horiuchi H; Kinoshita H; Shirouzu K
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1081-3. PubMed ID: 23986056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A Case of Long-Term Survival of a Patient with Cholangiocarcinoma and Liver Metastatic Recurrence Who Responded to Gemcitabine plus Cisplatin Therapy].
    Yachi T; Kimura N; Ishido K; Kudo D; Sakuraba S; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1991-1993. PubMed ID: 30692421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer.
    Doval DC; Sekhon JS; Gupta SK; Fuloria J; Shukla VK; Gupta S; Awasthy BS
    Br J Cancer; 2004 Apr; 90(8):1516-20. PubMed ID: 15083178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.